World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
151
Citations
95948
World Ranking
1109
National Ranking
638

Overview

Mark Schiffman is affiliated with the National Institutes of Health in the United States and contributes to the field of medicine, with a particular focus on epidemiology, surgery, microbiology, and cancer research.

Their work predominantly addresses cervical cancer and HPV research, hepatitis B virus studies, genital health and disease, microbial infections and disease, cancer-related molecular mechanisms, and reproductive tract infections.

Frequent publication venues for their research include:

  • JNCI Journal of the National Cancer Institute
  • JAMA Oncology
  • JNCI Monographs
  • The Lancet
  • International Journal of Cancer

Some of Mark Schiffman's recent notable papers are:

  • "Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial" (2020), JNCI Journal of the National Cancer Institute
  • "Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial" (2020), JNCI Journal of the National Cancer Institute
  • "Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant" (2020), JAMA Oncology
  • "A cervical cancer control strategy for lower-resource settings: interventions to complement one-dose HPV vaccination" (2024), JNCI Monographs
  • "The rational design of cervical cancer prevention strategies" (2024), The Lancet

Mark Schiffman has collaborated frequently with fellow researchers such as Troy J. Kemp, Sarah Wagner, Douglas R. Lowy, Lígia A. Pinto, and Aimée R. Kreimer.

Their research has concentrated on understanding vaccines' effectiveness and strategic planning for cervical cancer prevention, including studies on vaccine durability and immune responses in various populations.

This scientist's work has contributed to ongoing efforts in infectious disease control and cancer prevention, particularly in developing evidence-based vaccination schedules and intervention strategies tailored to resource-limited settings.

Best Publications

  • Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

    F X Bosch;M M Manos;N Muñoz;M Sherman

  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

    Debbie Saslow;Diane Solomon;Herschel W. Lawson;Maureen Killackey

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia

    Mark H. Schiffman;Heidi M. Bauer;Robert N. Hoover;Andrew G. Glass

  • The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice

    Michelle J. Khan;Philip E. Castle;Attila T. Lorincz;Sholom Wacholder

  • TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

    Patrick J. Killela;Zachary J. Reitman;Yuchen Jiao;Chetan Bettegowda

  • Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized Trial

    Diane Solomon;Mark Schiffman;Robert Tarone

  • Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels

    Ahmedin Jemal;Edgar P. Simard;Christina Dorell;Anne-Michelle Noone

  • Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.

    F. Xavier Bosch;Ann N. Burchell;Mark Schiffman;Anna R. Giuliano

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Carcinogenic human papillomavirus infection.

    Mark Schiffman;John Doorbar;Nicolas Wentzensen;Silvia de Sanjosé

  • Human Papillomavirus Testing in the Prevention of Cervical Cancer

    Mark Schiffman;Nicolas Wentzensen;Sholom Wacholder;Walter Kinney

  • Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica

    Rolando Herrero;Allan Hildesheim;Concepcion Bratti;Mark E. Sherman

  • Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women

    Allan Hildesheim;Mark H. Schiffman;Patti E. Gravitt;Andrew G. Glass

  • 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

    Rebecca B. Perkins;Richard S. Guido;Philip E. Castle;David Chelmow

  • Interim Guidelines for Management of Abnormal Cervical Cytology

    Robert J. Kurman;Donald E. Henson;Arthur L. Herbst;Kenneth L. Noller

  • Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.

    Mark Schiffman;Susanne Krüger Kjaer

  • TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL

    Hai Yan;P.J. Killela;Z.J. Reitman;Y. Jiao

Frequent Co-Authors

Nicolas Wentzensen
Nicolas Wentzensen National Institutes of Health
Rolando Herrero
Rolando Herrero Costa Rican Agency for Biomedical Research, INCIENSA Foundation
Allan Hildesheim
Allan Hildesheim National Institutes of Health
Robert D. Burk
Robert D. Burk Albert Einstein College of Medicine
Philip E. Castle
Philip E. Castle National Institutes of Health
Mark E. Sherman
Mark E. Sherman Mayo Clinic
Sholom Wacholder
Sholom Wacholder National Institutes of Health
Diane Solomon
Diane Solomon National Institutes of Health
Sophia S. Wang
Sophia S. Wang City Of Hope National Medical Center
Joan L. Walker
Joan L. Walker University of California, Berkeley

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA opens doors to numerous education paths beyond the traditional MD. Many students consider related online degrees in fields like administration, nursing, or pharmacy. These options often offer flexible study schedules and varying costs depending on the program.

A popular first step is exploring healthcare administration degree cost to understand your investment for entry-level or management roles. Those interested in advanced leadership positions often pursue a masters in healthcare administration cost, which can help predict future earning potential and career advancement.

Nursing professionals seeking higher credentials might consider cheap online dnp programs for a Doctor of Nursing Practice. Pharmacist roles also offer excellent job prospects—those comparing digital learning opportunities can review an online pharmacist degree for potential pathways and tuition rates.

Exploring these related online degrees helps students align their education with career goals, flexibility needs, and budget constraints—all important considerations in today’s evolving healthcare landscape.

Best Scientists Citing Mark Schiffman

Trending Scientists

Recently Published Articles